Rabbani N et al
There are several Phase 3 trials evaluating GLP-1s for conditions, such as prediabetes, Alzheimer's disease, diabetic retinopathy and osteoarthritis of the knee (in patients with obesity)
We dive deep into the mechanisms, the context, and the practical realities weve observed
If you notice persistent irritation, redness, or any unusual reactions, discontinue use and consult a dermatologist
[PubMed] [PMC] FabianFine R, Weaver AL, Roman AG, Winters MJ, DeWitt JC (2024) Myelinated glial cells: Their proposed role in waste clearance and neurodegeneration in arachnid and human brain
Moreover, 31.6% of tirzepatide participants lost 25% of body weight compared to 16.1% of semaglutide participants